Conventionally, the Indian pharmaceutical industry has been depended on a core competency in generics, manufacturing and comparatively unripened potentialities in Research & Development. This prospect has overhauled considerably since the 1990s and Indian companies have been making investments towards nourishing drug discovery and development activities.
The adoption of patent laws and the surge of contract manufacturing have preceded to the diversification of revenue streams, altering Indian pharma industry to go across high market growth.
Continue Reading @ https://bit.ly/2wH8rKc
For more updates visit HarNeedi.com